MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. Research has identified cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol) as key players in the plant’s therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

United Patients Group

JULY 29, 2024

Additionally, THC (tetrahydrocannabinol) offers psychoactive benefits that can alleviate anxiety and depression when used appropriately. For instance, incorporating CBD oil into your daily routine might provide long-term relief from persistent pain without the psychoactive effects associated with THC.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. THC is the psychoactive compound responsible for the “high” associated with marijuana use.

Law 52

Law Clinical Trials Dispensary Programs 52

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Approved Cannabinoid-Based Medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Approved Cannabinoid-Based Medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 27, 2022

Accessible via Australia’s Therapeutic Goods Administration (TGA) Special Access Scheme and Authorized Prescriber Scheme (where individual applications are approved), whole flower options including 1:1 (THC 10 CBD 10), mid-range (17), and high THC (25) varieties of 15g bag GMP-Certified medical cannabis will be made available.

Education 52

Education Research and Development Medicine Epilepsy 52

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. THC, for example, primarily binds to CB1 receptors, producing psychoactive effects and influencing mood, appetite, and pain perception.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

Cannabis Law Report

JULY 25, 2022

The term “marijuana” refers to parts or products in the Cannabis Sativa plant, but it contains substantial amounts of tetrahydrocannabinol (THC). Pennsylvania residents may still purchase CBD-infused products with under 0.03% THC. This article will help you understand the laws in Pennsylvania. Anxiety disorders. Crohn’s disease.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The drug does not contain any of the psycho-active component of cannabis, a compound called tetrahydrocannabinol (THC). What about other medical cannabis products? September 23, 2019.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. Rapidly growing research and personal reports suggest medical cannabis could be the answer.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

DECEMBER 9, 2019

Unlike its more nefarious cousin, THC, CBD does not elicit any psychostimulatory effects, meaning that consumers won’t get “high” from using it. Although research on CBD is still in its infancy, to date there have been dozens of studies with more on the horizon. Why so little research? Depression. Inflammation.

Pets 59

Pets CBD Research and Development Epilepsy 59

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

DECEMBER 7, 2021

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. Introduction. 18 years old).

Safety 52

Safety Cannabinoids Events Data 52

WeedAdvisor

MARCH 29, 2019

While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. The most extensive research involved patients with severe – often untreatable – epilepsy. Hemp, which falls under the cannabis umbrella, contains little THC and is almost entirely composed of CBD.

Oil 40

Oil CBD Research and Development Epilepsy 40

WeedAdvisor

APRIL 8, 2019

These companies source their CBD products from industrial hemp, which contains less than 1% THC. As long as the THC level is no higher than 0.3%, it is not considered a controlled substance. With this kind of accessibility, CBD’s popularity skyrocketed in all 50 states. Confirmed Benefits. . The post U.S.

Food 40

Food CBD Research and Development Treatment 40

The Joint Blog

JUNE 4, 2021

Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

United Patients Group

APRIL 24, 2023

In addition, cannabis might also help improve heart health by reducing inflammation around vessels; this reduces the risk of developing atherosclerosis (the hardening of arteries) or plaque buildup inside them. In addition to these potential side effects, some epilepsy medications have been linked with depression and suicidal thoughts.

Blood Pressure 52

Blood Pressure Sleep Cannabinoids Research and Development 52

Puff Puff Post

NOVEMBER 30, 2018

Unfortunately, we lack scientific research and studies on CBD and its effects on specific species. They want to push for access to CBD oil to treat sick animals. Based on anecdotal stories that CBD oil benefits pets, they also want more research studies to support these claims. So, where does this leave pet owners?

Pets 76

Pets Oil CBD Research and Development 76

The Joint Blog

SEPTEMBER 9, 2020

In our efforts to be honest and bring you the latest and updated information about CBD oil, we decided to do extensive research. Cannabis Sativa, the plant that people put in joints, contains two main cannabinoids – tetrahydrocannabinol (THC) and cannabidiol (CBD). Bear in mind that THC is the psychoactive compound here.

Oil 49

Oil CBD Vaping Hemp 49

Cannabis Law Report

APRIL 10, 2019

Just over 80 prescriptions for medical cannabis (THC and CBD) have been written, according to Hancock. “We The Government need to push for centres of excellence to help to stimulate the research they say they are calling for.”. To date, research has centred on two major cannabinoids, tetrahydrocannabinol and cannabidiol.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Joint Blog

MARCH 21, 2021

CBD (cannabidiol) is so often confused with its counterpart THC (tetrahydrocannabinol), which is the compound in weed that gets you “high”. CBD is one of over 100 cannabinoids, alongside THC, that can be found within the cannabis plant. So does the research support this? Depression. Chronic pain. Cancer-related symptoms.

Safety 26

Safety CBD Oil Cannabinoids 26

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. THC is the molecule responsible for the famous high associated with marijuana, but it also has a long list of therapeutic effects. What is THC? THC is short for tetrahydrocannabinol. Who discovered THC? THC vs CBD.

THC 98

THC Research and Development Cannabinoids CBD 98

MMJ Recs

SEPTEMBER 19, 2023

However, several common factors contribute to the development of chronic pain. Understanding all of these common causes is crucial for healthcare professionals to develop effective pain management strategies and improve the quality of life for individuals dealing with chronic pain.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Cannabis Law Report

JANUARY 27, 2020

The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. But what if a view develops suggesting that all this CBD could be causing health problems, not just resolving them?

Safety 59

Safety CBD Food Seed-To-Sale 59

Otherside Farms

MAY 6, 2019

ASD usually develops during childhood and is a neurodevelopmental condition which often involves compulsive and repetitive behavior. We still don’t know what causes the development of ASD, with scientists believing that it is probably a mixture of genetic and environmental factors. ASD and Epilepsy. How can CBD help with ASD?

Epilepsy 77

Epilepsy CBD Research and Development Therapy 77

The Cannigma

APRIL 7, 2022

We’ve got our regular segment with our Co-produces on this podcast with Americans for Safe Access. The thing was, is that I found that a little bit of cannabis and it could be, it’s really interesting, because it seems to work equally well with THC and CBD. If you A-Bed them with THC, you wouldn’t notice much of it.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

MGC Pharma

FEBRUARY 15, 2018

What will unrestricted access to Medicinal Cannabis look like in Australia? A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. kg of CBD and 163.7 kg of CBD and 163.7

Access 100

Access Medicine Chronic Pain Research and Development 100

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

FEBRUARY 1, 2020

More than 50 countries worldwide now permit access to regulated medical marijuana, and several nations–like South Africa and Mexico–have even legalised cultivation for personal use. While much of this development has been concentrated in Europe and the US, several nations in Asia-Pacific have also recently shifted towards greater tolerance.

Legalization 59

Legalization Research and Development Recreational Access 59

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. This process should also ensure appropriate funding allocated for this research.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

Mr. Laughter and Lawrence Ringo, an old-school hippie grower, were some of the first Americans to intentionally cultivate plants higher in CBD than in THC — the compound that does get you high. At the time of Samantha Miller’s summit in 2011, THC was the sole chemical “face” of the plant. San Francisco weekly.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 130

Legalization Patients Education Dispensary 130